Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Breast Neoplasms » Triple Negative Breast Neoplasms
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Breast Diseases » Breast Neoplasms » Triple Negative Breast Neoplasms
Description
Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN. MeSH
Hierarchy View
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (36)
Phase 2 Indicated Drugs (108)
Phase 1 Indicated Drugs (107)
Other Experimental Indicated Drugs (4)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (49)
China Breast Cancer Clinical Study Group
Chinese Academy of Medical Sciences
Frontier Science and Technology Research Foundation Inc (FS)
German Breast Group Forschungs GmbH
Istituto Oncologico Veneto IRCCS
Organization Involved with Phase 2 Indications (234)
Academic and Community Cancer Research United
Arbeitsgemeinschaft medikamentoese Tumortherapie
Associazione Italiana per la Ricerca sul Cancro
Azienda Ospedaliera San Gerardo di Monza
Big Ten Cancer Research Consortium
Breast Cancer Research Foundation
Cantonal Hospital of St. Gallen
Case Western Reserve University
Centro Nacional de Investigaciones Oncológicas
City of Hope National Medical Center
Clinica Universidad de Navarra
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
Infinity Pharmaceuticals, Inc.
Institut de Cancerologie de l'Ouest Paul Papin
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Istituti Ospitalieri di Cremona
Jiangxi Provincial Cancer Hospital
Memorial Sloan-Kettering Cancer Center
Methodist Cancer Center, Houston, Texas
National Cancer Institute, France
National Comprehensive Cancer Network
National Institutes of Health (NIH)
Norwegian University of Science and Technology
Oregon Health and Science University
Pharmaceutical Research Associates, Inc. (PRA)
Royal Marsden Hospital NHS Trust
Russian Academy of Medical Sciences
Russian Cancer Research Center
State University of New York, Buffalo
Susan G. Komen Breast Cancer Foundation
The Christie NHS Foundation Trust
The University of Texas, Dallas
Translational Breast Cancer Research Consortium
Trans Tasman Radiation Oncology Group
Triple Negative Breast Cancer Foundation
Universidad Autonoma de Barcelona
Universidad Complutense de Madrid
Université catholique de Louvain
University Hospital of North Norway
University of Alabama, Birmingham
University of California, San Francisco
University of Colorado, Denver
University of Illinois at Chicago
University of North Carolina at Chapel Hill
University of Southern Denmark
University of Texas at Houston
Virginia Commonwealth University
Organization Involved with Phase 1 Indications (50)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.